Data as of Jan 30
| -4.99 / -2.31%|
The 4 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 275.50, with a high estimate of 300.00 and a low estimate of 263.00. The median estimate represents a +30.52% increase from the last price of 211.08.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.